1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Myelodysplastic Syndromes (MDS) Research Fund is a grant from the Vera and Joseph Dresner Foundation that funds cutting-edge medical research and clinical trials specifically focused on myelodysplastic syndromes. The initiative aims to foster scientific innovation and improve future standards of care for MDS patients.
Eligible applicants are U.S.-based 501(c)(3) institutions including universities, colleges, hospitals, and laboratories. Principal Investigators must hold a doctoral-level degree (MD, PhD, DS, PharmD, or DO). Past recipients include early-career investigators at Johns Hopkins University, Memorial Sloan-Kettering Cancer Center, and H.
Lee Moffitt Cancer Center, with awards of $250,000 over two years. The application deadline for the current cycle was March 6, 2026.
Get alerted about grants like this
Get emailed when new opportunities from “Vera And Joseph Dresner Foundationinc” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Grant Process - Vera and Joseph Dresner Foundation An account allows you to access your saved and submitted applications at any time. It also allows us to send you a submission confirmation e-mail and notify you if additional information is necessary to process your application. Apply Here – Youth and Family, Health Access, and Animal Welfare Apply Here – MDS Research Fund Please log in using your E-mail Address and Password.
MDS Research Fund Application For more information about the Fund and to apply, please visit the MDS Research Fund page. The Vera and Joseph Dresner Foundation has awarded Forgotten Harvest a $240,000 grant to increase access for food-insecure children and families in southeast Michigan. The Vera and Joseph Dresner Foundation has awarded Food Gatherers a $100,000 grant to cover the increased cost associated with food purchasing.
Anderson Ranch Arts Center The Vera and Joseph Dresner Foundation has awarded Anderson Ranch Arts Center $44,000 to provide approximately 20 at-risk youth with a one-week art immersion workshop. Ypsilanti District Library The Vera and Joseph Dresner Foundation has awarded Ypsilanti District Library a $18,000 grant to expand existing and develop new youth and family programming.
The Vera and Joseph Dresner Foundation has awarded Dumb Friends League a $150,000 grant for direct care costs associated with veterinary care for underserved, low-income families. The Vera and Joseph Dresner Foundation granted Johns Hopkins University a $250,000 grant over two years for early career investigator Dr. Kristen E. Schratz.
Memorial Sloan-Kettering Cancer Center Memorial Sloan-Kettering Cancer Center was awarded a $250,000 grant over two years to support early career researcher Dr. Richard J. Lin. H.
Lee Moffitt Cancer Center The Vera and Joseph Dresner Foundation granted H Lee Moffitt Cancer Center a $250,000 grant for early career investigator Dr. David A. Sallman.
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: U.S.-based 501(c)(3) institutions (universities, colleges, hospitals, or laboratories). Principal Investigators must hold a doctoral-level degree (MD, PhD, DS, PharmD, or DO). Confirm the full requirements in the official notice before applying.
The published deadline was March 6, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Myelodysplastic Syndromes (MDS) Research Fund is funded by Vera And Joseph Dresner Foundationinc. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The solicitation lists 7 required documents: Letter of Intent (LOI) via YourCause portal, Full proposal via YourCause portal (by invitation only), Project budget using foundation's downloadable .docx template, Letter of support from institutional President/CEO or designated official, Letter from authorized institutional signer accepting Research Grant Agreement terms, and Complete disclosure of all funding sources, among others (the full list is in the Required Documents section on this page). Check the official notice for formatting and page-limit rules.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.